Product
Salovum
1 clinical trial
3 indications
Indication
Breast CancerIndication
DiarrheaIndication
Adverse Drug EventClinical trial
A Randomized Double-blind Placebo Controlled Phase 3 Trial on the Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer - the ASF-BC StudyStatus: Recruiting, Estimated PCD: 2024-10-31